Bernstein Autonomous analysts Nadine Sarwat and Trevor Stirling share what they know so far about Ozempic, Wegovy and other diet/diabetes drugs’ effect on alcoholic beverage consumption.
Sarwat and Stirling break down why these drugs have entered popular culture conversations, what users are saying about their cravings, comparisons to past diet trends and much more.
Also, Jess, Zoe and Justin discuss the latest news, including promotions at Rhinegeist, the failed union effort at Creature Comforts and non-alcoholic beer reaching its limit at retail.
Listen to the conversation on popular podcast platforms, including Apple, Google Play and Spotify.
Send questions, feedback or ideas for the podcast to podcast@brewbound.com.